Anne Efron

1.3k total citations
13 papers, 976 citations indexed

About

Anne Efron is a scholar working on Infectious Diseases, Epidemiology and General Health Professions. According to data from OpenAlex, Anne Efron has authored 13 papers receiving a total of 976 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 9 papers in Epidemiology and 2 papers in General Health Professions. Recurrent topics in Anne Efron's work include Tuberculosis Research and Epidemiology (8 papers), HIV/AIDS Research and Interventions (5 papers) and Pneumocystis jirovecii pneumonia detection and treatment (5 papers). Anne Efron is often cited by papers focused on Tuberculosis Research and Epidemiology (8 papers), HIV/AIDS Research and Interventions (5 papers) and Pneumocystis jirovecii pneumonia detection and treatment (5 papers). Anne Efron collaborates with scholars based in United States, Brazil and South Africa. Anne Efron's co-authors include Richard E. Chaisson, Jonathan E. Golub, Lawrence H. Moulton, Solange Cavalcante, Betina Durovni, Valéria Saraceni, Antônio Guilherme Pacheco, Bonnie King, Marcus Barreto Conde and Gary Maartens and has published in prestigious journals such as The Lancet, PLoS ONE and The Lancet Infectious Diseases.

In The Last Decade

Anne Efron

13 papers receiving 951 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anne Efron United States 12 861 650 199 166 82 13 976
Mark Hawken Kenya 20 743 0.9× 565 0.9× 235 1.2× 187 1.1× 89 1.1× 30 1.0k
Nonhlanhla Yende‐Zuma South Africa 18 667 0.8× 444 0.7× 157 0.8× 188 1.1× 163 2.0× 72 1.0k
Anushka Naidoo South Africa 14 569 0.7× 415 0.6× 165 0.8× 71 0.4× 84 1.0× 34 804
Themba Moeti Botswana 13 761 0.9× 593 0.9× 256 1.3× 72 0.4× 64 0.8× 22 958
Vivian Cox South Africa 17 629 0.7× 398 0.6× 104 0.5× 126 0.8× 132 1.6× 42 734
Virginia De Azevedo South Africa 19 770 0.9× 527 0.8× 166 0.8× 122 0.7× 89 1.1× 32 972
Howard Moffat United States 16 775 0.9× 489 0.8× 179 0.9× 78 0.5× 284 3.5× 17 980
Micheal Mugerwa Uganda 16 645 0.7× 519 0.8× 268 1.3× 81 0.5× 40 0.5× 25 816
Mohammed Rassool South Africa 11 573 0.7× 325 0.5× 124 0.6× 69 0.4× 144 1.8× 25 764
Solange Cavalcante Brazil 20 1.3k 1.5× 1.1k 1.6× 391 2.0× 109 0.7× 51 0.6× 48 1.5k

Countries citing papers authored by Anne Efron

Since Specialization
Citations

This map shows the geographic impact of Anne Efron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Efron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Efron more than expected).

Fields of papers citing papers by Anne Efron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Efron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Efron. The network helps show where Anne Efron may publish in the future.

Co-authorship network of co-authors of Anne Efron

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Efron. A scholar is included among the top collaborators of Anne Efron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Efron. Anne Efron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Kendall, Emily A., Betina Durovni, Neil Martinson, et al.. (2019). Adherence to tuberculosis preventive therapy measured by urine metabolite testing among people with HIV. AIDS. 34(1). 63–71. 9 indexed citations
2.
Conde, Marcus Barreto, Fernanda Carvalho de Queiroz Mello, Rafael Silva Duarte, et al.. (2016). A Phase 2 Randomized Trial of a Rifapentine plus Moxifloxacin-Based Regimen for Treatment of Pulmonary Tuberculosis. PLoS ONE. 11(5). e0154778–e0154778. 25 indexed citations
3.
4.
Duwell, Monique, Amy R. Knowlton, Jean B. Nachega, et al.. (2013). Patient-Nominated, Community-Based HIV Treatment Supporters: Patient Perspectives, Feasibility, Challenges, and Factors for Success in HIV-Infected South African Adults. AIDS Patient Care and STDs. 27(2). 96–102. 36 indexed citations
5.
Durovni, Betina, Valéria Saraceni, Lawrence H. Moulton, et al.. (2013). Effect of improved tuberculosis screening and isoniazid preventive therapy on incidence of tuberculosis and death in patients with HIV in clinics in Rio de Janeiro, Brazil: a stepped wedge, cluster-randomised trial. The Lancet Infectious Diseases. 13(10). 852–858. 74 indexed citations
6.
7.
Guerra, Renata Leborato, Marcus Barreto Conde, Anne Efron, et al.. (2010). Point-of-care Arkansas method for measuring adherence to treatment with isoniazid. Respiratory Medicine. 104(5). 754–757. 21 indexed citations
8.
Durovni, Betina, Solange Cavalcante, Valéria Saraceni, et al.. (2010). The implementation of isoniazid preventive therapy in HIV clinics: the experience from the TB/HIV in Rio (THRio) Study. AIDS. 24(Suppl 5). S49–S56. 45 indexed citations
9.
Nachega, Jean B., Richard E. Chaisson, René Goliath, et al.. (2010). Randomized controlled trial of trained patient-nominated treatment supporters providing partial directly observed antiretroviral therapy. AIDS. 24(9). 1273–1280. 78 indexed citations
10.
Dooley, Kelly E., Anne Efron, Richard E. Chaisson, et al.. (2009). T-SPOT.TBresponses during treatment of pulmonary tuberculosis. BMC Infectious Diseases. 9(1). 23–23. 56 indexed citations
11.
Conde, Marcus Barreto, Anne Efron, Malathi Ram, et al.. (2009). Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial. The Lancet. 373(9670). 1183–1189. 210 indexed citations
12.
Golub, Jonathan E., Valéria Saraceni, Solange Cavalcante, et al.. (2007). The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil. AIDS. 21(11). 1441–1448. 240 indexed citations
13.
Nachega, Jean B., Amy R. Knowlton, Andrea N. DeLuca, et al.. (2006). Treatment Supporter to Improve Adherence to Antiretroviral Therapy in HIV-Infected South African Adults. JAIDS Journal of Acquired Immune Deficiency Syndromes. 43(Supplement 1). S127–S133. 154 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark Hawken Breakdown of academic impact, for papers by Nonhlanhla Yende‐Zuma Breakdown of academic impact, for papers by Anushka Naidoo Breakdown of academic impact, for papers by Themba Moeti Breakdown of academic impact, for papers by Vivian Cox Breakdown of academic impact, for papers by Virginia De Azevedo Breakdown of academic impact, for papers by Howard Moffat Breakdown of academic impact, for papers by Micheal Mugerwa Breakdown of academic impact, for papers by Mohammed Rassool Breakdown of academic impact, for papers by Solange Cavalcante
Rankless by CCL
2026